Biostate AI closes $12M to bring the Netflix model to molecular diagnostics
Posted:
Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. The company’s immediate focus is revolutionizing RNAseq accessibility and developing clinically relevant predictive models.
At GIANT Health Event #GIANT2025, Rajesh Sivaprakasam, Lead for Robotic Renal Failure Surgery at Barts Health NHS Trust, shared powerful insights in an interview with EMJ on how operating theatres have evolved over the last decade.
He highlighted a major…
At GIANT Health 2025, Hassan Chaudhury HonFAPM chaired the Innovating NHS Systems Congress, leading vital discussions on how innovation can truly deliver impact across healthcare.
In his EMJ interview, Hassan shared a clear perspective on innovation — highlighting that it…
Attendees
Sponsors and Exhibitors
Contact us